DOAC
Showing 51 - 75 of 167
Elaboration ofPrioritization Score for Pharmaceutical Interviews
Completed
- Thromboembolic Event
- Survey
-
Reims, FranceChu Reims
Oct 19, 2023
Radial Artery Occlusion Trial in Kingston, Ottawa (Rivaroxaban 15 MG Oral Tablet [Xarelto])
Recruiting
- Radial Artery Occlusion
- Rivaroxaban 15 MG Oral Tablet [Xarelto]
-
Kingston, Ontario, Canada
- +1 more
Feb 8, 2022
Polypharmacy, Insomnia, Anticoagulants Trial in Ann Arbor (Academic Detailing (AD), LEAP)
Recruiting
- Polypharmacy
- +2 more
- Academic Detailing (AD)
- LEAP
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System, Ann Arbor, MI
Jul 18, 2022
Coagulation Disorder Trial in Groningen (VMX-C001, Placebo, Apixaban)
Recruiting
- Coagulation Disorder
- VMX-C001
- +4 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Dec 7, 2021
Medicines That Help in Thinning Blood in People With Atrial
Not yet recruiting
- Atrial Fibrillation
- No OAC
- +4 more
- (no location specified)
Apr 28, 2023
Hip Fractures Trial in Calgary (Rivaroxaban 10mg, acetylsalicylic acid (ASA) 81mg Oral Tablet)
Not yet recruiting
- Hip Fractures
- Rivaroxaban 10mg
- acetylsalicylic acid (ASA) 81mg Oral Tablet
-
Calgary, Alberta, CanadaFoothills Medical Centre
Mar 7, 2023
Subdural Hematoma, Atrial Fibrillation Trial in Toronto (Direct Acting Oral Anticoagulant starting at Day 30, Direct Acting Oral
Not yet recruiting
- Subdural Hematoma
- Atrial Fibrillation
- Direct Acting Oral Anticoagulant starting at Day 30
- Direct Acting Oral Anticoagulant starting at Day 90
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jul 26, 2022
Concentration of Direct Oral Anticoagulants in Atrial
Not yet recruiting
- Oral Anticoagulant
- +2 more
- (no location specified)
Dec 23, 2020
Healthy Volunteer Trial in Leeds (Aspirin, rivaroxaban low dose, rivaroxaban high dose)
Recruiting
- Healthy Volunteer
- Aspirin
- +2 more
-
Leeds, West Yorkshire, United KingdomLabCorp CRU
Jan 24, 2023
COVID-19 Trial in London (Aspirin 75mg, Clopidogrel 75mg, Rivaroxaban 2.5 MG)
Terminated
- COVID-19
- Aspirin 75mg
- +4 more
-
London, United KingdomCharing Cross Hospital
Jan 13, 2023
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments
Completed
- Hemophilia A
- +2 more
- Vitamin K Antagonist - Drug
-
Brest, France
- +5 more
Apr 6, 2023
Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)
Active, not recruiting
- Venous Thrombosis
- +2 more
- 12-month Edoxaban
- 3-month Edoxaban
-
Kyoto, JapanDepartment of Cardiovascular Medicine, Kyoto University Graduate
Aug 16, 2022
Oral Anticoagulants in Italian Elderly Non-Valvular Atrial
Recruiting
- Non-Valvular Atrial Fibrillation (NVAF)
-
Milano, MI, ItalyEcol Studio SpA
Jan 31, 2022
Adherence, Medication, Statin Adverse Reaction, Anticoagulant Adverse Reaction Trial (Questionnaires to report barriers to
Recruiting
- Adherence, Medication
- +2 more
- Questionnaires to report barriers to medication adherence
-
Leeds, West Yorkshire, United KingdomLeeds Teaching Hospitals Trust
Aug 24, 2022
Knowledge, Attitudes, Practice Trial (Anticoagulation Educational Materials, Control Group: Standard of Care)
Not yet recruiting
- Knowledge, Attitudes, Practice
- Anticoagulation Educational Materials
- Control Group: Standard of Care
- (no location specified)
Nov 17, 2023
Atrial Fibrillation Trial in Ottawa (Apixaban, Rivaroxaban)
Recruiting
- Atrial Fibrillation
-
Ottawa, Ontario, CanadaThe Ottawa Hospital - General Campus
Mar 14, 2022
Esophageal Cancer, Gastric Cancer Trial in Worldwide (Surveillance protocol)
Not yet recruiting
- Esophageal Cancer
- Gastric Cancer
- Surveillance protocol
-
Cologne, Germany
- +12 more
Oct 29, 2023
Direct Oral Anticoagulants for the Treatment of Mural Thrombus
Completed
- Acute Myocardial Infarction
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021
Direct Oral Anticoagulants (DOACs) in Hypercoagulable States
Completed
- Hypercoagulable States
- Observational
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021
Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical Trial in United States (Sham comparator, DrugSorb-ATR
Recruiting
- Hemorrhage, Surgical
- +3 more
- Sham comparator
- DrugSorb-ATR system
-
Sacramento, California
- +23 more
Jul 20, 2022
Pancreas Cancer, DVT, Pulmonary Embolism Trial in Philadelphia (Apixaban)
Completed
- Pancreas Cancer
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Clinical Research Unit
Dec 6, 2021
Myocardial Infarction, Acute, Left Ventricular Thrombus Trial in Paris (Rivaroxaban 2.5 MG [Xarelto], DAPT strategy)
Recruiting
- Myocardial Infarction, Acute
- Left Ventricular Thrombus
- Rivaroxaban 2.5 MG [Xarelto]
- DAPT strategy
-
Paris, FranceHEGP
Oct 22, 2021
Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)
Not yet recruiting
- Anticoagulants; Increased
- catheter induced thromboprophylaxis
- (no location specified)
Jan 21, 2023
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Venous Thromboembolism Trial in Canada (Apixaban, Rivaroxaban)
Recruiting
- Venous Thromboembolism
-
Calgary, Alberta, Canada
- +16 more
Mar 14, 2022